You are viewing: Europe Veterinary PoC Diagnostics Market analysis

The Europe Veterinary PoC Diagnostics Market was valued at $303 Million in 2026 and projected to reach to $427.2 Million by 2031, representing a compound annual growth rate of 7.1%. Europe's veterinary PoC diagnostics market is positioned for steady growth, expanding from $303.0 million in 2026 to $427.2 million by 2031 at a 7.1% CAGR.

Europe Veterinary PoC Diagnostics Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Veterinary PoC Diagnostics Market Trends and Insights

  • This growth trajectory reflects Europe's strong emphasis on animal health, regulatory compliance, and the adoption of rapid diagnostic technologies across veterinary clinics and animal hospitals.
  • Europe's mature healthcare infrastructure and high pet ownership rates continue to drive demand for accessible, efficient diagnostic solutions in the region. The European market benefits from advanced veterinary practices, stringent animal welfare standards, and increasing investment in diagnostic innovation.
  • Europe's veterinary professionals are increasingly adopting PoC diagnostics to improve clinical decision-making and reduce time-to-diagnosis for companion and livestock animals.
  • Between 2026 and 2031, Europe is expected to see sustained growth driven by technological advancements, rising awareness of preventive care, and the integration of digital health solutions in veterinary settings across the continent..

Key Market Statistics

  • CAGR (2026-2031) 7.1% CAGR
  • Market Size, 2026 ~USD 303 Million
  • Forecast, 2031 ~USD 427.2 Million
  • Geography Europe

Europe Veterinary PoC Diagnostics Market Overview

Market Leadership by Germany :

Germany dominates Europe's veterinary PoC diagnostics market with a valuation of $103.6 million in 2026, driven by advanced veterinary infrastructure, high pet ownership rates, and stringent animal health regulations that mandate rapid diagnostic capabilities.

Strong Regulatory Framework :

Europe's robust regulatory environment, including EU veterinary directives and animal welfare standards, accelerates adoption of point-of-care diagnostics across member states, ensuring compliance and standardized diagnostic protocols in veterinary practices.

Premium Pet Care Market :

European consumers demonstrate high spending on pet healthcare, with countries like the UK ($79.3M) and France ($69.8M) showing significant investment in preventive and diagnostic services, supporting market expansion through 2031.

Technological Integration :

European veterinary clinics increasingly adopt digital-enabled PoC diagnostics, integrating results with electronic health records and practice management systems, enhancing operational efficiency and clinical decision-making across the region.

Europe Veterinary PoC Diagnostics Market Dynamics

  • This growth is underpinned by increasing pet ownership, rising awareness of zoonotic diseases, and the European Union's emphasis on animal health surveillance and biosecurity measures.
  • Major markets like Germany, the UK, and France lead adoption due to advanced veterinary infrastructure and high disposable incomes. The region's growth trajectory will be supported by technological innovations in rapid diagnostics, integration with digital veterinary platforms, and expanding distribution networks across smaller European markets.
  • Regulatory harmonization within the EU facilitates market penetration, while growing demand for preventive care and early disease detection in companion and livestock animals continues to drive investment in point-of-care diagnostic solutions throughout the forecast period..

Related Ecosystem

Key Takeaways

  • Europe's veterinary PoC diagnostics market is valued at $303.0 million in 2026 and will reach $427.2 million by 2031, growing at 7.1% CAGR.
  • Europe's advanced veterinary infrastructure and high pet ownership rates are primary drivers of PoC diagnostic adoption across the region.
  • Regulatory compliance and animal welfare standards in Europe are accelerating the shift toward rapid, point-of-care diagnostic solutions.
  • Digital health integration and preventive care initiatives are expected to sustain Europe's market growth through 2031.

Veterinary PoC Diagnostics Market Report Scope

Report Metric Details
Base Year 2026
Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
Forecast Period 2026–2031
Growth Rate CAGR of 7.7% from 2026 to 2031
Largest Segment CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.19 (2026)
Revenue Forecast (Billions) ~USD 1.72 (2031)
Segments Covered Product, Animal Type, Type, Technology, Livestock Type, Molecular Diagnostics

Europe Veterinary PoC Diagnostics Market Report Segmentation

6 segment dimensions are covered across the global market.

By Product

  • Consumables
  • Instruments

By Animal Type

  • Companion Animals
  • Livestock

By Type

  • Cat
  • Cattle
  • Crispr-Based
  • Dog
  • Horse
  • Isothermal Amplification
  • Other Companion Animals
  • Other Livestock
  • Pcr-Based
  • Pig
  • Poultry

By Technology

  • Immunodiagnostics
  • Molecular Diagnostics
  • Other Technologies

By Livestock Type

  • Cattle
  • Other Livestock
  • Pig
  • Poultry

By Molecular Diagnostics

  • Crispr-Based
  • Isothermal Amplification
  • Pcr-Based

Target Audience

  • Veterinary Diagnostic Manufacturers : Manufacturers need Europe-specific market data to develop localized product portfolios, understand regulatory requirements by country, and identify high-potential markets for PoC diagnostic device launches and expansion.
  • Veterinary Clinic Operators : Clinic owners and managers require market insights to justify investments in PoC diagnostic equipment, benchmark adoption rates against competitors, and optimize service offerings based on regional demand trends.
  • Healthcare Investors & PE Firms : Investment professionals need detailed European market segmentation to evaluate acquisition targets, assess growth potential in veterinary diagnostics, and identify consolidation opportunities across regional markets.
  • Veterinary Distributors & Suppliers : Distributors require country-level market data to optimize inventory management, identify underserved regions, and develop targeted sales strategies for point-of-care diagnostic products across European territories.
  • Regulatory & Policy Advisors : Consultants and policy experts need market intelligence to advise on veterinary diagnostic standards, assess market readiness for new technologies, and guide regulatory compliance strategies across EU member states.

Key Companies in the Europe Veterinary PoC Diagnostics Market

CompanyHQOwnershipStrongest segments
GENERAL ELECTRICUnited StatesPublic CompanyCommercial Engines & Services,Defense & Propulsion Technologies,Additive and Advanced Components,
IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group (in-clinic analyzers, reference labs, software, services),Livestock, Poultry and Dairy Diagnostics,Water Quality Products,
THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
BIOMéRIEUXFrancePublic CompanyMicrobiology ID/AST systems (VITEK 2, VITEK MS, VITEK REVEAL, API, ETEST),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Sepsis, immunoassay, and specialty markers (VIDAS, Hybiome CLIA),
VIRBACFrancePublic CompanyCompanion animal parasiticides (e.g., Prevexto),Companion animal chronic-care nutrition (e.g., Vikaly, petfood),Behavior and stress management (Zenidog/Zenifel),

GENERAL ELECTRIC

General Electric is a publicly traded United States company founded in 1892 that operates with 57,000 employees.

IDEXX LABORATORIES, INC.

IDEXX Laboratories, Inc. is a publicly traded United States company founded in 1983 with 11,000 employees.

THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc. is a publicly traded United States company founded in 1956 with 125,000 employees.

BIONOTE

BioNote is a publicly traded South Korean company founded in 2003 with 298 employees.

BIOMéRIEUX

bioMérieux is a publicly traded French company founded in 1963 with 14,894 employees.

VIRBAC

Virbac is a publicly traded French company founded in 1968 with 6,442 employees.

Europe vs. other regions

HowEurope compares to the other 3 regional blocs covered in this market.

North America
~USD 816.5 Million · 7.5% wtd CAGR ·
Asia Pacific
~USD 398.4 Million · 9.2% wtd CAGR ·
Latin America
~USD 55 Million · 6.5% wtd CAGR ·

Countries within Europe - compare and drill down

Country2025 size (native)
GermanyUSD 103.6 Million
UKUSD 79.3 Million
FranceUSD 69.8 Million
ItalyUSD 48.8 Million
SpainUSD 32.8 Million
NetherlandsUSD 26.6 Million
SwedenUSD 11.1 Million
PolandUSD 8.8 Million
Rest Of EuropeUSD 46.6 Million

Country market size visualization

Germany
USD 103.6 Million
UK
USD 79.3 Million
France
USD 69.8 Million
Italy
USD 48.8 Million
Spain
USD 32.8 Million
Netherlands
USD 26.6 Million
Sweden
USD 11.1 Million
Poland
USD 8.8 Million
Rest Of Europe
USD 46.6 Million

Reasons to Buy this Report

  • Country-Level Market Segmentation : Access detailed market valuations for 8 European countries including Germany ($103.6M), UK ($79.3M), and France ($69.8M), enabling precise market targeting and localized business strategy development.
  • Regulatory Compliance Insights : Understand Europe's stringent veterinary diagnostic regulations and EU compliance requirements that drive adoption, helping stakeholders navigate market entry and product certification pathways across member states.
  • Competitive Landscape Analysis : Identify market leaders and growth opportunities across European regions, with insights into regional preferences for diagnostic technologies and competitive positioning strategies specific to each country.
  • Growth Forecasting Through 2031 : Leverage 5-year projections showing 7.1% CAGR growth to plan product launches, expansion timelines, and resource allocation for capturing emerging opportunities in Europe's veterinary diagnostics sector.
  • Strategic Partnership Opportunities : Identify high-growth markets and distribution partners across Europe, with data-driven insights into regional demand patterns and veterinary practice adoption rates for point-of-care diagnostic solutions.

Frequently asked questions

What is the current size of Europe's veterinary PoC diagnostics market?

Europe's veterinary PoC diagnostics market is valued at $303.0 million in 2026 and is expected to grow to $427.2 million by 2031.

What is the projected growth rate for Europe's veterinary PoC diagnostics market?

Europe's veterinary PoC diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2031.

What factors are driving growth in Europe's veterinary PoC diagnostics market?

Key drivers include Europe's advanced veterinary infrastructure, high pet ownership rates, stringent animal welfare regulations, and increasing adoption of digital health solutions in veterinary practices.

How does Europe's veterinary PoC diagnostics market compare to global trends?

Europe's 7.1% CAGR is slightly below the global average of 7.7%, reflecting the region's mature market status and established veterinary diagnostic infrastructure.

Which segments are expected to drive Europe's veterinary PoC diagnostics market growth?

Growth is expected across companion animal diagnostics, livestock health monitoring, and integrated digital health platforms that enable rapid clinical decision-making in European veterinary settings.

RESEARCH METHODOLOGY

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; and white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary PoC diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary PoC diagnostics market. Primary sources from the demand side include small and large animal veterinarians, veterinary clinic and hospital owners, managers of livestock farms and dairy operations, directors of veterinary diagnostic laboratories, officials from government animal health and regulatory agencies, and procurement and purchasing teams from veterinary clinics, hospitals, and farm operations.

A breakdown of the primary respondents is provided below:

Breakdown Of Primary Interviews: Supply-Side Participants, By Company Type, Designation, And Region

Veterinary PoC Diagnostics Market
 Size, and Share

Note: C-level executives include CEOs, COOs, CTOs, and VPs.

Other designations include sales, marketing, and product managers.

Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the veterinary PoC diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Veterinary PoC Diagnostics Market : Top-Down and Bottom-Up Approach

Veterinary PoC Diagnostics Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

The veterinary PoC diagnostics market comprises products and technologies used for rapid, on-site diagnosis of diseases and health conditions in animals, enabling immediate clinical decision-making without reliance on centralized laboratories. The market includes consumables (such as test kits, cartridges, strips, and reagents) and instruments (including portable analyzers and handheld diagnostic devices) and covers key technologies such as molecular diagnostics (PCR-based, isothermal amplification, and CRISPR-based methods), immunodiagnostics, and other techniques, including clinical chemistry and hematology. It serves both companion animals (dogs, cats, horses, and others) and livestock (cattle, pigs, poultry, and others), with applications spanning infectious disease detection, routine health monitoring, and preventive care across veterinary clinics, farms, and field settings.

Key Stakeholders

  • Veterinary PoC diagnostic kit manufacturers
  • Molecular diagnostic technology providers & PoC instrument manufacturers
  • Reagent & consumable suppliers
  • Veterinary clinics & hospitals
  • Livestock farms, dairy farms & integrated animal production companies
  • Government animal health authorities & surveillance agencies
  • Veterinary diagnostic laboratories
  • Veterinarians & field-based animal health service providers
  • Academic & veterinary research institutions
  • Contract manufacturers & OEM partners
  • Distributors & regional channel partners
  • Market research & consulting firms
  • Investors & venture capital firms

Report Objectives

  • To define, describe, segment, and forecast the veterinary PoC diagnostics market by product, technology, animal type, and region, in terms of value
  • To define, describe, segment, and forecast the veterinary PoC diagnostics market by product and region, in terms of volume
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary PoC diagnostics market
  • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies2
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the veterinary PoC diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the veterinary PoC diagnostics market and comprehensively analyze their core competencies and market shares
  • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

1. Micromarkets are defined as the further segments and subsegments of the veterinary PoC diagnostics market included in the report.

2. Core competencies of companies are captured in terms of the key developments and strategies adopted by them to sustain their market positions.

Available customizations:

With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of Rest of Europe veterinary PoC diagnostics market into Austria, Finland, Switzerland, and other countries
  • Further breakdown of Rest of Latin America veterinary PoC diagnostics market into Colombia, Chile, and other countries

Competitive Landscape Assessment

Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary PoC diagnostics market

  • Competitive leadership mapping for established players in the US

Get the Full Veterinary PoC Diagnostics Market Report

Full forecast, segment splits, and company analysis for all Veterinary PoC Diagnostics Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status